Source: Health Canada shortage reports · Updated Jul 14, 2026
Some Clomipramine products are in shortage in Canada (1 of 4 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A tricyclic antidepressant used to treat obsessive-compulsive disorder and depression.
Products affected
1 / 4
In shortage since
Jun 2, 2026
Reports on file
17
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · since Jun 2, 2026, est. end Jun 26, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Jun 22, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
25MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497506 · ended Jun 22, 2026 · Shortage of an active ingredient.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Apr 23, 2026 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
50MG · TABLET · APOTEX INC
DIN 00402591 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Dec 22, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Oct 30, 2024 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
25MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497506 · ended Jan 31, 2024 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
50MG · TABLET · APOTEX INC
DIN 00402591 · ended Dec 21, 2023 · Disruption of the manufacture of the drug.
Resolved
TARO-CLOMIPRAMINE
50MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 02497514 · ended Jan 30, 2023 · Disruption of the manufacture of the drug.
Resolved
ANAFRANIL
25MG · TABLET · APOTEX INC
DIN 00324019 · ended Apr 1, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 17 reports. All reports are on file with Health Canada.
What's happening
Clomipramine is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Clomipramine is classified under “ANTIDEPRESSANTS” (ATC N06AA).
Recent changes
Jul 14, 2026
Shortage resolved
Jul 14, 2026
Shortage resolved
Common questions
What is Clomipramine used for?
A tricyclic antidepressant used to treat obsessive-compulsive disorder and depression.
When will Clomipramine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Clomipramine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.